Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF195 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | SGK1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | ZNF239 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | SURF2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | C19orf53 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | MAP4K5 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | CHRD | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | RPS6 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | KLHL42 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | VWDE | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |